STOCK TITAN

Concentra Group (NYSE: CON) details Dr. John Anderson’s 2027 consulting and equity terms

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. outlined post-retirement arrangements for Executive Vice President and Chief Medical Officer Dr. John R. Anderson. Following his previously disclosed retirement effective December 31, 2026, Dr. Anderson will transition to a part-time consulting role with subsidiary Concentra Health Services, Inc.

The consulting agreement is effective from January 1, 2027 through December 31, 2027, with either party able to terminate on 30 days’ notice and Concentra able to terminate immediately for Cause. Dr. Anderson will provide up to 10 hours of consulting services per week at $216.00 per hour, and his outstanding unvested restricted stock awards under the 2024 Equity Incentive Plan will continue to vest during the term while he provides services. If he completes the term without termination for Cause or voluntary resignation, 25% of his then-unvested restricted stock will vest, while all unvested equity will be forfeited upon earlier termination for Cause or voluntary resignation, subject to execution of specified releases.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Consulting term start January 1, 2027 Effective date of Dr. Anderson’s consulting agreement
Consulting term end December 31, 2027 Scheduled expiration of the consulting agreement term
Hourly consulting rate $216.00 per hour Compensation rate for up to 10 hours per week of consulting services
Weekly consulting hours cap 10 hours per week Maximum time commitment under the consulting agreement
Automatic vesting portion 25% of then-unvested restricted stock Portion that vests if Dr. Anderson completes the full consulting term without termination for Cause or voluntary resignation
Notice period for termination 30 days Written notice required by either party to terminate the consulting agreement, absent Cause
Consulting Agreement regulatory
"entered into a consulting agreement, pursuant to which Dr. Anderson will serve as an independent contractor"
Cause regulatory
"Concentra may terminate the Consulting Agreement immediately for Cause"
restricted stock awards financial
"outstanding unvested restricted stock awards granted under the Concentra Group Holdings Parent, Inc. 2024 Equity Incentive Plan"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Equity Incentive Plan financial
"restricted stock awards granted under the Concentra Group Holdings Parent, Inc. 2024 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
general release of claims regulatory
"subject to Dr. Anderson’s execution of a general release of claims upon the commencement of the Term"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What executive change did Concentra Group Holdings Parent, Inc. (CON) report for Dr. John R. Anderson?

Dr. John R. Anderson will retire as Executive Vice President and Chief Medical Officer effective December 31, 2026. He will then serve as a part-time independent contractor consultant to Concentra Health Services, Inc. under a new consulting agreement effective January 1, 2027.

What are the key terms of Dr. Anderson’s consulting role with Concentra (CON)?

Dr. Anderson will provide up to 10 hours of consulting services per week at $216.00 per hour. The consulting term runs from January 1, 2027 through December 31, 2027, unless earlier terminated under the agreement’s notice and Cause provisions.

How will Dr. Anderson’s equity awards be treated under the Concentra (CON) consulting agreement?

Outstanding unvested restricted stock awards under the 2024 Equity Incentive Plan will continue to vest during the consulting term if he keeps providing services. If he completes the full term, 25% of his then-unvested restricted stock will automatically vest, subject to required releases.

What happens to Dr. Anderson’s unvested equity if his consulting with Concentra (CON) ends early?

If Dr. Anderson is terminated for Cause or voluntarily resigns before December 31, 2027, all of his unvested equity awards will be immediately forfeited. The equity benefits are also conditioned on signing a general release and a final release of claims.

Can the consulting agreement between Dr. Anderson and Concentra (CON) be terminated early?

Yes. Either party may terminate the consulting agreement at any time with 30 days’ prior written notice. Concentra may also terminate immediately for Cause, as defined in Dr. Anderson’s employment agreement dated November 19, 2010, as amended.
FALSE000201459600020145962026-07-062026-07-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
_______________

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 6, 2026
_______________
CONCENTRA GROUP HOLDINGS PARENT, INC.

(Exact Name of Registrant as Specified in Its Charter)
_______________

001-42188
(Commission File Number)
Delaware
30-1006613
(State or Other Jurisdiction of Incorporation)
(I.R.S. Employer Identification No.)

5080 Spectrum Drive, Suite 1200W
Addison, TX, 75001
(Address of principal executive offices) (Zip code)

(972) 364-8000
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, $0.01 par value per share
 
CON
 
New York Stock Exchange
 
 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):




Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Agreements of Certain Officers.

Consulting Agreement

As previously disclosed, on April 10, 2026, Dr. John R. Anderson notified Concentra Group Holdings Parent, Inc. (the “Company”) of his retirement from his position as Executive Vice President and Chief Medical Officer of the Company effective as of December 31, 2026.

In connection with Dr. Anderson’s retirement, on July 6, 2026, Concentra Health Services, Inc., a subsidiary of the Company (“Concentra”), and Dr. Anderson entered into a consulting agreement, pursuant to which Dr. Anderson will serve as an independent contractor providing part-time consulting services to Concentra following his retirement (the “Consulting Agreement”). The Consulting Agreement becomes effective on January 1, 2027 (the “Effective Date”) and has a term through December 31, 2027 (the “Term”), unless earlier terminated. Either party may terminate the Consulting Agreement at any time upon 30 days’ prior written notice to the other party. Concentra may terminate the Consulting Agreement immediately for Cause (as defined in Dr. Anderson’s Employment Agreement with Concentra dated November 19, 2010, as amended).

Under the Consulting Agreement, Dr. Anderson will provide consulting services for up to 10 hours per week at a rate of $216.00 per hour in connection with clinical strategy, medical affairs, regulatory matters, and such other matters as may be reasonably requested. The Consulting Agreement provides that Dr. Anderson’s outstanding unvested restricted stock awards granted under the Concentra Group Holdings Parent, Inc. 2024 Equity Incentive Plan will continue to vest during the Term, provided that Dr. Anderson continues to provide consulting services through each applicable vesting date. If Dr. Anderson completes the full Term without being terminated for Cause or voluntarily resigning, 25% of Dr. Anderson’s then-unvested restricted stock will automatically vest. If Dr. Anderson is terminated for Cause or voluntarily resigns prior to the expiration of the Term, all of Dr. Anderson’s unvested equity awards will be immediately forfeited. The equity benefits are subject to Dr. Anderson’s execution of a general release of claims upon the commencement of the Term and a final release upon the expiration or earlier termination of the Consulting Agreement.

The foregoing description of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Consulting Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number
Description
10.1*
Consulting Agreement, dated as of July 6, 2026, by and between Concentra Health Services, Inc. and Dr. John Anderson.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Indicates a management contract or compensatory plan or arrangement.



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CONCENTRA GROUP HOLDINGS PARENT, INC.
Date: July 10, 2026
By:
/s/ Timothy Ryan
Timothy Ryan
Executive Vice President and Chief Legal Counsel




Filing Exhibits & Attachments

4 documents